InnovaRx Innova Health Strategies
PricingSign in

U07.1

Bookmark

COVID-19

Filed alongside this entry 585

under Disease, diseased

Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.

Billable FY2027 2026-10-01 → 2027-09-30 FY2021–2027 only
How to use this page

Everything the published sources say about one code, on one page.

  1. Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
  2. Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
  3. Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
  4. Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
  5. Risk-model chips show which published CMS models map this code.

What this page does not do

  • Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
  • Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".

All page guides →

Exclusions2never code together
U07.1code
Excludes2
  • coronavirus as the cause of diseases classified elsewhere (B97.2-)B97.2-B97.2-
  • pneumonia due to SARS-associated coronavirus (J12.81)J12.81J12.81

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes7
U07.1code
Use additional code
  • code to identify pneumonia or other manifestations, such as:
  • pneumonia due to COVID-19 (J12.82)J12.82J12.82
  • code, if applicable, for associated conditions such as:
  • COVID-19 associated coagulopathy (D68.8)D68.8D68.8
  • disseminated intravascular coagulation (D65)D65D65
  • hypercoagulable states (D68.69)D68.69D68.69
  • thrombophilia (D68.69)D68.69D68.69
Official Guidelines1

ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.

I.C.22 Chapter 22: Codes for Special Purposes (U00-U85) chapter guidance p.107

U07.0 Vaping-related disorder (see Section I.C.10.e., Vaping-related disorders) U07.1 COVID-19 (see Section I.C.1.g.1., COVID-19 infection) U09.9 Post COVID-19 condition, unspecified (see Section I.C.1.g.1.m.)

Index entries leading here5
  • Coronavirus (infection)
  • Syndrome — see also Disease
    • severe acute respiratory (SARS) J12.81
  • Infection, infected, infective (opportunistic) B99.9
  • COVID-19 U07.1
  • Disease, diseased — see also Syndrome
Alongside this code1same parent — U07
U07.0 Vaping-related disorder
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2027
Parent
U07
Block
U00-U49
Siblings
1

Present FY2021–FY2027.